Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 1—January 2007

Research

Model for Assessing Human Papillomavirus Vaccination Strategies

Elamin H. Elbasha*Comments to Author , Erik J. Dasbach*, and Ralph P. Insinga*
Author affiliations: *Merck Research Laboratories, North Wales, Pennsylvania, USA;

Main Article

Figure 8

Impact of age that vaccination was begun on cervical cancer incidence due to human papillomavirus 16/18 infection among girls and women >12 years of age.

Figure 8. Impact of age that vaccination was begun on cervical cancer incidence due to human papillomavirus 16/18 infection among girls and women >12 years of age.

Main Article

TOP